Literature DB >> 11920552

Ethnic differences in survival among women with ovarian carcinoma.

Jill S Barnholtz-Sloan1, Michael A Tainsky, Judith Abrams, Richard K Severson, Faisal Qureshi, Suzanne M Jacques, Nancy Levin, Ann G Schwartz.   

Abstract

BACKGROUND: Ovarian carcinoma is the leading cause of death among all female reproductive malignancies. There are substantial differences in age-adjusted incidence rates and survival rates between Caucasian women and African-American women. The objective of this study was to examine ethnic differences in survival after ovarian carcinoma in a population-based sample of women.
METHODS: Thirteen thousand eighty-three patients (12285 Caucasian women and 798 African-American women) who were diagnosed with primary ovarian carcinoma from the population-based Surveillance, Epidemiology, and End Results (SEER) Program were used for analysis. Odds ratios were used to estimate the association between prognostic variables and ethnicity. Chi-square tests were used to determine the statistical significance of these associations (using two-sided P values). Univariable and multivariable Cox proportional hazards models were used to assess survival differences.
RESULTS: African-American women were significantly younger at the time of diagnosis, were more likely to be single, and were less likely to undergo site specific surgery compared with Caucasian women. In addition, the crude median survival for African-American women was nearly 1 year less than for Caucasian women (22 months vs. 32 months, respectively; P < 0.0001). African-American women were at a 30% increased risk of death from any cause when adjusting for all other prognostic variables that differed between the two ethnic groups.
CONCLUSIONS: African-American women who are diagnosed with ovarian carcinoma are at a significant increased risk of death from any cause compared with Caucasian women who are diagnosed with ovarian carcinoma. Copyright 2002 American Cancer Society.

Entities:  

Mesh:

Year:  2002        PMID: 11920552     DOI: 10.1002/cncr.10415

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  21 in total

1.  Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status.

Authors:  Robert E Bristow; Jenny Chang; Argyrios Ziogas; Hoda Anton-Culver; Veronica M Vieira
Journal:  Gynecol Oncol       Date:  2014-03-25       Impact factor: 5.482

2.  Spatial analysis of advanced-stage ovarian cancer mortality in California.

Authors:  Robert E Bristow; Jenny Chang; Argyrios Ziogas; Daniel L Gillen; Lu Bai; Veronica M Vieira
Journal:  Am J Obstet Gynecol       Date:  2015-01-31       Impact factor: 8.661

3.  Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.

Authors:  Sherri L Stewart; Rhea Harewood; Melissa Matz; Sun Hee Rim; Susan A Sabatino; Kevin C Ward; Hannah K Weir
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

4.  Quality of life among women after surgery for ovarian cancer.

Authors:  Dena Schulman-Green; Elizabeth Ercolano; Michael Dowd; Peter Schwartz; Ruth McCorkle
Journal:  Palliat Support Care       Date:  2008-09

5.  Gender- and Race-Based Differences in Barriers and Facilitators to Early Detection of Colon Cancer.

Authors:  Katherine C Brewer; Nadine R Peacock; Carol E Ferrans; Richard T Campbell; Blase Polite; Leslie Carnahan; Lindsey A Jones; Garth H Rauscher
Journal:  J Womens Health (Larchmt)       Date:  2020-02-25       Impact factor: 2.681

6.  Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.

Authors:  Robert E Bristow; Matthew A Powell; Noor Al-Hammadi; Ling Chen; J Philip Miller; Phillip Y Roland; David G Mutch; William A Cliby
Journal:  J Natl Cancer Inst       Date:  2013-03-28       Impact factor: 13.506

7.  Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer.

Authors:  Mishka Terplan; Sarah Temkin; Ana Tergas; Ernst Lengyel
Journal:  Gynecol Oncol       Date:  2008-09-26       Impact factor: 5.482

8.  Disparities in use of gynecologic oncologists for women with ovarian cancer in the United States.

Authors:  Shamly Austin; Michelle Y Martin; Yongin Kim; Ellen M Funkhouser; Edward E Partridge; Maria Pisu
Journal:  Health Serv Res       Date:  2012-12-03       Impact factor: 3.402

9.  Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials.

Authors:  John H Farley; Chunqiao Tian; G Scott Rose; Carol L Brown; Michael Birrer; G Larry Maxwell
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

10.  The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago.

Authors:  Charlotte E Joslin; Katherine C Brewer; Faith G Davis; Kent Hoskins; Caryn E Peterson; Heather A Pauls
Journal:  Gynecol Oncol       Date:  2014-08-28       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.